baber/WOPTO huggingface dataset:
Patent AU-2017379072-B2 (AU)
Title: Color separation in waveguides using dichroic filters
Inventor: YEOH IVAN LI CHUEN
IPC: G02B27/44
Filed: 2017-12-21
Granted: 2021-11-04
Abstract: An eyepiece for projecting an image to an eye of a viewer includes a first planar waveguide positioned in a first lateral plane, a second planar waveguide positioned in a second lateral plane adjacent the first lateral plane, and a third planar waveguide positioned in a third lateral plane adjacent the second lateral plane. The first waveguide includes a first diffractive optical element (DOE) coupled thereto and disposed at a lateral position. The second waveguide includes a second DOE coupled thereto and disposed at the lateral position. The third waveguide includes a third DOE coupled thereto and disposed at the lateral position. The eyepiece further includes a first optical filter disposed between the first waveguide and the second waveguide at the lateral position, and a second optical filter positioned between the second waveguide and the third waveguide at the lateral position.
Patent AU-2017381868-B2 (AU)
Title: A method for manufacturing a thermally treated steel sheet
Inventor: BONNET FRÉDÉRIC
IPC: C21D9/573
Filed: 2017-12-20
Granted: 2020-10-08
Abstract: The present invention relates to a method for manufacturing a thermally treated steel sheet.
Patent AU-2018214147-B2 (AU)
Title: Modified Antibody Compositions, Methods of Making and Using Thereof
Inventor: STAGLIANO NANCY E
IPC: G01N33/53
Filed: 2018-08-10
Granted: 2020-06-04
Abstract: The present disclosure provides modified antibodies which contain an antibody or antibody fragment (AB) modified with a masking moiety (MM). Such modified antibodies can be further coupled to a cleavable moiety (CM), resulting in activatable antibodies (AAs), wherein the CM is capable of being cleaved, reduced, photolysed, or otherwise modified. AAs can exhibit an activatable conformation such that the AB is more accessible to a target after, for example, removal of the MM by cleavage, reduction, or photolysis of the CM in the presence of an agent capable of cleaving, reducing, or photo lysing the CM. The disclosure further provides methods of making and using such modified antibodies and activatable antibodies.
Patent AU-2018256263-B2 (AU)
Title: Injectable composition for localized fat reduction without pain, edema, and side effects, and method for preparing same
Inventor: LEE KI TAEK
IPC: A61K31/685
Filed: 2018-04-20
Granted: 2021-05-06
Abstract: The present invention relates to an injectable composition for topical fat reduction without pain, edema, and side effects, and a method for preparing the same and, more specifically, to an injectable composition for topical fat reduction, wherein the injectable composition contains a particular mixing ratio of glycocholic acid (or a salt thereof) or taurocholic acid (or a salt thereof) and phosphatidylcholine (PPC), and thus causes no pain, edema, and side effects, such as necrosis of muscle cells, fibroblasts, vascular endothelial cells, besides adipocytes, anesthesia of a site of administration, extensive swelling, erythema, hardening, abnormal sensation, nodules, itching, burning sensation, nerve damage, and aphagopraxia, and to a method for preparing the composition. A DCA single injection, which has been known as an existing injection for topical fat reduction, or a composition of a PPC injection mixed with DCA as a solubilizer, is accompanied by pain and side effects, such as anesthesia, extensive swelling, topical edema, erythema, hardening, abnormal sensation, nodules, itching, burning sensation, and aphagopraxia, due to necrosis necessarily caused by lysis of even fibroblasts, vascular endothelial cells, and muscle cells, besides adipocytes, so that patients complain of pain, discomfort, and anxiety, and show low drug compliance, but the injection for topical fat reduction of the present invention has an excellent composition, which improves the quality of lives of patients and increases the drug compliance since the preparation is safe and stable and has excellent lipolysis and adipocytic apoptosis inducing effects, selectively to only adipocytes, leading to no side effects described above.
Patent AU-2018260981-B2 (AU)
Title: Optical fiber and slanted fiber grating
Inventor: NAGANO SHIGEHIRO
IPC: G02B6/028
Filed: 2018-11-13
Granted: 2023-11-30
Abstract: OF THE DISCLOSURE 
An optical fiber is made of silica-based glass and includes a core, a first cladding 
that surrounds the core and that has a refractive index lower than a refractive index of the 
core; and a second cladding that surrounds the first cladding and that has a refractive index 
lower than the refractive index of the core and higher than the refractive index of the first 
cladding. At least a part of the first cladding contains a photosensitive material whose 
refractive index increases by irradiation with light having a specific wavelength. A 
difference An between a refractive index of a portion of the first cladding, the portion 
being nearest to the core, and the refractive index of the core is in a range of 0.25% to 
0.30%. The radius ra of the core is larger than 4.3 pm and smaller than or equal to 5.0 pm.
Patent AU-2018261030-B2 (AU)
Title: Stimulated rock volume analysis
Inventor: RATERMAN KEVIN T
IPC: G01V1/42
Filed: 2018-05-07
Granted: 2023-07-06
Abstract: A data acquisition program, which includes core, image log, microseismic, DAS, DTS, and pressure data, is described. This program can be used in conjunction with a variety of techniques to accurately monitor and conduct well stimulation.
Patent AU-2018269320-B2 (AU)
Title: Preterm infant formula containing butyrate and uses thereof
Inventor: BERSETH CAROL LYNN
IPC: A23L33/19
Filed: 2018-05-15
Granted: 2021-02-18
Abstract: Provided are preterm infant formulas containing dietary butyrate. Further disclosed are methods for promoting or accelerating myelination and optimizing myelination development in preterm infants via administering the preterm infant formulas disclosed herein.
Patent AU-2018271160-B2 (AU)
Title: Beverage dispensing assembly and beverage container
Inventor: PAAUWE ARIE MAARTEN
IPC: B67D1/04
Filed: 2018-05-18
Granted: 2023-11-16
Abstract: Beverage dispensing assembly and beverage container Beverage dispensing assembly (1), comprising a dispenser (2) and a beverage container (3), wherein the beverage container (3) has a neck portion (7) and a shoulder portion (8) adjacent the neck portion (7), wherein the neck portion (7) is provided with at least an outflow opening and at least one gas inlet opening (9) and wherein the dispenser (2) comprises a housing (4), wherein the housing (4) is provided with a receptacle (5) for receiving at least part of the container (3), wherein the container (3) is positioned in the dispenser (2) with the neck (7) and shoulder portion (8) facing downward, such that the neck portion (7) and at least part of the shoulder portion (8) are received in the receptacle (5), wherein part of the shoulder portion (8) extends close to and/or is in contact with a wall of the receptacle (5), wherein preferably a lid (12) is provided over the container (3), enclosing a part of the container (3) extending outside the receptacle (5).
Patent AU-2018281131-B2 (AU)
Title: Pyrazolopyrimidine PDE9 inhibitors
Inventor: ARASAPPAN ASHOK
IPC: A61K31/519
Filed: 2018-06-06
Granted: 2022-01-20
Abstract: The present invention is directed to pyrazolopyrimidine compounds which may be useful as therapeutic agents for the treatment of disorders associated with phosphodiesterase 9 (PDE9). The present invention also relates to the use of such compounds for treating cardiovascular and cerebrovascular diseases, such as hypertension, chronic kidney disease and heart failure, and neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.
Patent AU-2018303848-B2 (AU)
Title: Axial-load- actuated rotary latch release mechanism
Inventor: SLACK MAURICE WILLIAM
IPC: E21B19/16
Filed: 2018-07-20
Granted: 2023-06-08
Abstract: A rotary latch release mechanism includes axially-aligned upper and lower rotary latch components carried on and rotationally coupled to upper and lower latch assemblies, respectively. The latch release mechanism is movable from an axially-latched position to an axially-unlatched position in response to relative rotation between the upper and lower rotary latch components. The latch release mechanism has a movable land surface that acts in response to relative axial displacement to induce the relative rotation required to release the latch. The latch release mechanism may be configured such that the axial movement of the movable land surface will cause the relative axial movement required to release the latch in combination with the required rotation. Accordingly, the rotary latch mechanism operates in response to externally-controlled axial movement of a movable land surface carried by the latch release mechanism, without requiring externally-induced rotation.
Patent AU-2018371813-B2 (AU)
Title: Polylactic acid composite material and application thereof
Inventor: LU CHANGLI
IPC: C08L71/02
Filed: 2018-06-26
Granted: 2020-12-24
Abstract: The invention discloses a polylactic acid composite material and application thereof. The polylactic acid composite comprises the following components: (A) 89-98 parts by weight of polylactic acid; (B) 1-4 parts by weight of talc powder; and (C) 1-7 parts by weight of a plasticizer. For the component (A), the polylactic acid has a dispersity index P satisfying the relationship: 1.55 ≤ P ≤ 2.02. For the component (B), the talc powder has a particle diameter D
Patent AU-2019257444-B2 (AU)
Title: Containers and methods for dispensing multiple doses of a concentrated liquid, and shelf stable concentrated liquids
Inventor: RAGNARSSON KARL
IPC: B65D47/20
Filed: 2019-10-30
Granted: 2021-10-21
Abstract: Containers and methods are provided for dispensing a liquid 
concentrate utilizing one or more desirable properties including a generally 
consistent discharge across a range of squeeze forces, a generally consistent 
discharge with the same force without significant dependence on the amount of 
liquid concentrate in the container, a substantially dripless or leak proof outlet 
opening, a jet that minimizes splashing when the liquid concentrate impacts a 
target liquid, and a jet that maximizes mixing between the liquid concentrate 
and the target liquid to produce a generally homogenous mixture without the 
use of extraneous utensils or shaking. Also provided are liquid beverage 
concentrates that can be cold filled during packaging, while maintaining shelf 
stability for at least twelve months at ambient temperatures. Concentrate can 
have a combination of low pH and high alcohol content such as a pH less than 
3.5 and alcohol content greater than 5 percent by weight.
Patent AU-2019257516-B2 (AU)
Title: Patient support apparatuses with wireless headwall communication
Inventor: BHIMAVARAPU KRISHNA SANDEEP
IPC: A61G7/00
Filed: 2019-11-01
Granted: 2021-07-08
Abstract: There is disclosed a person support apparatus system for a healthcare facility, the person support 
apparatus system comprising: a person support apparatus having a support surface adapted to 
support a person; a first transceiver attached to the person support apparatus; a plurality of 
headwall interfaces mounted to a plurality of headwalls within the healthcare facility, each of the 
headwall interfaces having a second transceiver adapted to wirelessly communicate with the first 
transceiver, and each of the headwall interfaces having a unique identifier, each of the headwall 
interfaces coupled to a connector of a nurse call system and each of the connectors mounted to 
one of the plurality of headwalls; a third transceiver attached to the person support apparatus; and 
a controller coupled to the person support apparatus and adapted to establish a communication 
link with a specific one of the headwall interfaces by sending a signal to the specific headwall 
interface via the first transceiver, the signal including the unique identifier for the specific 
headwall interface, and wherein the controller receives the unique identifier via the third 
transceiver.
Patent AU-2019280005-B2 (AU)
Title: Automated document analysis comprising a user interface based on content types
Inventor: COOK DAVID A
IPC: G06F40/295
Filed: 2019-12-11
Granted: 2022-02-10
Abstract: AUTOMATED DOCUMENT ANALYSIS COMPRISING A USER INTERFACE BASED 
ONCONTENTTYPES 
ABSTRACT 
At least one processing device, operating upon a body of text in a document, identifies 
occurrences of at least one content type in the body of text. The at least one processing device 
thereafter generates a user interface that includes portions of text from the body of text that are 
representative of at least some of the occurrences of the at least one content type in the 
document. For each content type, the occurrences corresponding to that content type can be 
grouped together to provide grouped content type occurrences that are subsequently collocated in 
the user interface. Those portions of text corresponding to the grouped content type occurrences 
may be arranged in alphanumeric order. The user interface may comprise at least a portion of 
the body of text as well as indicia indicating instances of the occurrences within the portion of 
the body of text.  
19
(114 r 
110 
NETWORK PERIPHERAL 
104 INTERFACE INTERFACE 
116 STORAGE 102 
EXECUTABLE 1--108 
118 INSTRUCTIONS PROCESSOR(S) DISPLAY 
100USER INPUT -w HE 
106 112 
FIG. 1 
[------------------------------------
202 
p CTRC1 
204 
TEXT CTRC 2 UIER 
209 
208 2 210 200 
SCTRC N 
206
FIG. 2
Patent AU-2019290497-B2 (AU)
Title: Capacitance reducing battery submodule with thermal runaway propagation prevention and containment features
Inventor: MELACK JOHN
IPC: H01M10/48
Filed: 2019-06-13
Granted: 2021-10-21
Abstract: A battery system includes a can with a lip around an opening. At least an interior surface of the can is anodized and the lip of the can includes a longer and shorter side. The can further includes a flange on the longer side of the lip and a plurality of layers that are inserted into the can. The plurality of layers includes a battery cell and a thermally conducting layer with a fin and the fin has a spring force that pushes the fin towards the anodized interior surface. The battery system further includes a lid that is configured to cover the opening of the can, where the flange is configured to wrap around the lid when the lid covers the opening of the can.
Patent AU-2019292101-B2 (AU)
Title: Battery management system
Inventor: SUZUKI DAISUKE
IPC: B60L53/62
Filed: 2019-06-26
Granted: 2023-05-25
Abstract: [Problem] To provide a battery management system for an electrical vehicle that is suitable for a sharing service. [Solution] A battery management system 100 includes: an electric vehicle 2 that can travel as a result of being driven by a motor powered by an exchangeable battery 1; a battery station 3 that can adjust a charging rate and charge the battery 1; and a management server 4 that is connected to the electric vehicle 2 and the battery station 3 via a communication network. The management server 4: quantitatively evaluates the exchangeability of the battery 1 stored in the battery station 3 on the basis of at least the position of the electric vehicle 2 and the remaining cell power of the battery 1 mounted in the electric vehicle 2; determines a charging rate for charging the battery 1 by the battery station 3 on the basis of an evaluation value for the exchangeability of the battery 1; and sends control information related to the determined charging rate to the battery station 3.
Patent AU-2019299864-B2 (AU)
Title: Shielding structure of safety inspection equipment and safety inspection channel
Inventor: HOU HONGBIN
IPC: G01V5/00
Filed: 2019-05-29
Granted: 2021-11-25
Abstract: True Translation 
LZ1904276CN08-AU 
ABSTRACT 
A shielding structure of a safety inspection equipment and a safety inspection channel 
are provided. The shielding structure of the safety inspection equipment includes a first 
carbon fiber layer, a polyurethane layer and a second carbon fiber layer, which are 
sequentially stacked to be configured as a shielding channel with two opened ends. The 
second carbon fiber layer is an outer layer of the shielding channel. The first carbon fiber 
layer and the second carbon fiber layer are made of carbon fiber materials. The polyurethane 
layer is made of polyurethane materials. In the present disclosure, the polyurethane board 
layer is added between the two carbon fiber layers, since the carbon fiber layer has good 
strength, the carbon fiber layers are covered on the both sides of the polyurethane board to 
ensure the overall strength, so that the rigidity of the shielding structure can be improved.  
And the rigidity of the shielding structure has little influence on the imaging quality, so that 
the rigidity of the shielding structure can be improved while reducing the influence on the 
imaging quality. In addition, the polyurethane board layer has small density, so that the 
polyurethane board layer is lighter than the carbon fiber layer, and thus the total weight can 
be reduced. And, cost of the polyurethane board layer is low, thus reducing the overall cost.  
[Fig.3] 
15
Patent AU-2019302611-B2 (AU)
Title: Composition of Fused Tricyclic gamma-Amino Acid Derivatives and the Preparation Thereof
Inventor: ZHANG XUANMIAO
IPC: A61P29/00
Filed: 2019-07-12
Granted: 2022-02-17
Abstract: Disclosed are a pharmaceutical composition of a fused tricyclic γ-amino acid derivative and the use thereof. The pharmaceutical composition comprises: (i) the structure as shown in formula (I) or a pharmaceutically acceptable salt thereof, as an active substance, wherein the weight percentage is 1%-45%; (ii) optionally one or more fillers, wherein the weight percentage is 50%-95%; and (iii) optionally one or more lubricants, wherein the weight percentage is 0.1%-5.5%. The sum of the weight percentages of all components is 100%. The structure of the pharmaceutically acceptable salt of the structure as shown in formula (I) is as shown in formula (I-A).
Patent AU-2019325956-B2 (AU)
Title: A drape for an imaging system gantry
Inventor: DALEY II EDWARD J
IPC: A61B46/27
Filed: 2019-08-06
Granted: 2021-09-23
Abstract: An imaging system gantry patient channel drape includes a gantry first outer sidewall covering portion including an outer rim biased into a deployed (e.g., circular) shape and collapsible, and a gantry inner (e.g, circular) wall covering portion extending inward of the gantry first outer sidewall covering portion.
Patent AU-2019356977-B2 (AU)
Title: Separation of ethane oxidative dehydrogenation effluent
Inventor: SAN ROMAN MACIA MARIA
IPC: C07C11/04
Filed: 2019-10-31
Granted: 2021-10-07
Abstract: The invention relates to a process for the production of ethylene by oxidative dehydrogenation of ethane, comprising: a) subjecting a stream comprising ethane to oxidative dehydrogenation conditions, resulting in a stream comprising ethylene, unconverted ethane and light components; b) subjecting ethylene, unconverted ethane and light components from the stream resulting from step a) to distillation, resulting in a stream comprising ethylene and light components and a stream comprising unconverted ethane; c) optionally recycling unconverted ethane from the stream comprising unconverted ethane resulting from step b) to step a); and d) subjecting ethylene and light components from the stream comprising ethylene and light components resulting from step b) to distillation at a top column pressure which is higher than the top column pressure in step b), resulting in a stream comprising light components and a stream comprising ethylene.
Patent AU-2020201728-B2 (AU)
Title: Deuterated analogs of etifoxine, their derivatives and uses thereof
Inventor: DASSE OLIVIER
IPC: A61K31/536
Filed: 2020-03-09
Granted: 2021-12-23
Abstract: This invention relates to deuterated analogs of etifoxine of Formula I, solvates, 
prodrugs, and pharmaceutically acceptable salts thereof, as well as to methods for their 
preparation and use, and to pharmaceutical compositions.  
x1x 
HN1IX12 X2 x 
HN D 
N O X2 
X3 X2 
X3 X3 
CI 
48
WO 2016/154039 PCT/US2016/023231 
2000 
1800 
1600 
S A 
1400 
E 1200 
1000 -4-Etifoxine 
-,-Example 1 
400 
2 004 
0 2 4 6 8 10 121 
Figure 1: Mean plasma concentration-time profiles of etifoxine and example 1 after 
a PO dose of 50 mg/kg in male Sprague-Dawley rats
Patent AU-2020203649-B2 (AU)
Title: Disruptive dressing for use with negative pressure and fluid instillation
Inventor: INGRAM SHANNON C
IPC: A61M1/00
Filed: 2020-06-03
Granted: 2022-03-17
Abstract: A method and apparatus for disrupting material at a tissue site is described. A contact layer 
may be selected for use on the tissue site and positioned adjacent to the tissue site. The 
contact layer may include walls defining a plurality of through-holes. A sealing member may be 
positioned over the contact layer and sealed to tissue surrounding the tissue site to form a 
sealed space enclosing the contact layer. A negative-pressure source may be fluidly coupled to 
the sealed space. The negative-pressure source may supply negative pressure to the sealed 
space and the contact layer to draw tissue into the through-holes to form nodules. The negative 
pressure may be vented from the sealed space to release the nodules.  
FIG. 1
1/13 
3 
;/ 
c 
rCD
Patent AU-2020260382-B2 (AU)
Title: Spraying apparatus and methods and components relating to spraying apparatus
Inventor: EASTON CAMPBELL BRYCE
IPC: B05B3/00
Filed: 2020-10-23
Granted: 2022-12-08
Abstract: A spraying apparatus that is particularly suited to spraying of suspensions, for 
example liquid suspended fertilizers. Spray outlets are arranged in a flow loop 
5 and only a proportion of fluid passing through the flow loop is sprayed with the 
remaining fluid returning to the tank for recirculation. Pressure-actuated closures 
may be used to prevent spraying until pressure has built up sufficiently.
Patent AU-2020323276-B2 (AU)
Title: Refrigerant piping and refrigeration device
Inventor: HAMADATE JUNICHI
IPC: B23K1/00
Filed: 2020-06-23
Granted: 2023-10-19
Abstract: Refrigerant piping (10A) comprises a first pipe (21) and a second pipe (22). The first pipe (21) has a stainless steel pipe main body (21a) and a connection pipe (21b) that is provided in an end section of the pipe main body (21a) in the pipe axis direction and comprises a material different from stainless steel. The connection pipe (21b) has a protruding section (21b1) that protrudes from the end of the pipe main body (21a), in the pipe axis direction. The second pipe (22) comprises: a second large diameter section (22a) that comprises the same material as the connection pipe (21b) and is arranged at the end in the pipe axis direction; a second small diameter section (22b) having a smaller diameter than the second large diameter section (22a); and a step section (22c) arranged between the second large diameter section (22a) and the second small diameter section (22b). The connection pipe (21b) is inserted in the second large diameter section (22a) and the protruding section (21b1) is in contact with the step section (22c). The outer circumferential surface of the connection pipe (21b) is connected to the inner circumferential surface of the second large diameter section (22a).